FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956604098> ?p ?o ?g. }

• W2956604098 endingPage "9" @default.
• W2956604098 startingPage "1" @default.
• W2956604098 abstract "Oral treprostinil may be an option for low‐ and intermediate‐risk patients with pulmonary arterial hypertension, a rare lung vascular disease. This open‐label extension study collected data on participants who completed previously reported, placebo‐controlled oral treprostinil studies. Eligible participants had completed the prospective parent studies and took increasing doses of oral treprostinil twice daily; some later transitioned to three times daily dosing. Investigators measured 6‐minute walk distance at Month 12 as the sole efficacy measure but collected adverse events throughout the study. A single center measured pharmacokinetics in 13 subjects who changed dosing from twice daily to three times daily. Eight hundred and ninety‐four participants enrolled and 71% completed one year of therapy, with a median total daily dose of 7 mg and a median 6‐minute walk distance increase of 22 m (interquartile range, −14 to 67 m). Subjects achieving higher doses had larger increases in 6‐minute walk distance; 42% of participants completed three years of therapy. Adverse events were typical for prostacyclin class therapy, but prostacyclin‐type adverse events may have been better tolerated with three times daily dosing in 105 participants. In 13 participants transitioned to three times daily dosing with pharmacokinetic measurements before and after, trough drug levels were higher with three times daily dosing. Oral treprostinil is associated with modest but durable, dose‐responsive effects on exercise tolerance for those who remained on therapy at one year in this prospective, uncontrolled study. Three times daily dosing was associated with higher trough levels and better tolerability. The recently completed Freedom‐EV study will provide further insights into the utility of oral treprostinil ( https://clinicaltrials.gov/show/NCT01560624 )." @default.
• W2956604098 created "2019-07-23" @default.
• W2956604098 creator A5029042843 @default.
• W2956604098 creator A5052192249 @default.
• W2956604098 creator A5057396658 @default.
• W2956604098 creator A5061207130 @default.
• W2956604098 creator A5062378470 @default.
• W2956604098 creator A5062468469 @default.
• W2956604098 creator A5073502710 @default.
• W2956604098 creator A5074845684 @default.
• W2956604098 creator A5077261260 @default.
• W2956604098 creator A5082154683 @default.
• W2956604098 creator A5086084700 @default.
• W2956604098 creator A5090409167 @default.
• W2956604098 date "2020-10-01" @default.
• W2956604098 modified "2023-09-25" @default.
• W2956604098 title "Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics" @default.
• W2956604098 cites W1840736932 @default.
• W2956604098 cites W1866413456 @default.
• W2956604098 cites W1979969712 @default.
• W2956604098 cites W2004950293 @default.
• W2956604098 cites W2007508594 @default.
• W2956604098 cites W2096352797 @default.
• W2956604098 cites W2099314224 @default.
• W2956604098 cites W2102192501 @default.
• W2956604098 cites W2110637500 @default.
• W2956604098 cites W2112229901 @default.
• W2956604098 cites W2118064892 @default.
• W2956604098 cites W2124275351 @default.
• W2956604098 cites W2129282733 @default.
• W2956604098 cites W2158657788 @default.
• W2956604098 cites W2161450347 @default.
• W2956604098 cites W2235524605 @default.
• W2956604098 cites W2278696749 @default.
• W2956604098 cites W2310399527 @default.
• W2956604098 cites W2321522617 @default.
• W2956604098 cites W2429455173 @default.
• W2956604098 cites W2466807627 @default.
• W2956604098 cites W2550771792 @default.
• W2956604098 cites W4241487982 @default.
• W2956604098 doi "https://doi.org/10.1177/2045894019866335" @default.
• W2956604098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7731723" @default.
• W2956604098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31290359" @default.
• W2956604098 hasPublicationYear "2020" @default.
• W2956604098 type Work @default.
• W2956604098 sameAs 2956604098 @default.
• W2956604098 citedByCount "0" @default.
• W2956604098 crossrefType "journal-article" @default.
• W2956604098 hasAuthorship W2956604098A5029042843 @default.
• W2956604098 hasAuthorship W2956604098A5052192249 @default.
• W2956604098 hasAuthorship W2956604098A5057396658 @default.
• W2956604098 hasAuthorship W2956604098A5061207130 @default.
• W2956604098 hasAuthorship W2956604098A5062378470 @default.
• W2956604098 hasAuthorship W2956604098A5062468469 @default.
• W2956604098 hasAuthorship W2956604098A5073502710 @default.
• W2956604098 hasAuthorship W2956604098A5074845684 @default.
• W2956604098 hasAuthorship W2956604098A5077261260 @default.
• W2956604098 hasAuthorship W2956604098A5082154683 @default.
• W2956604098 hasAuthorship W2956604098A5086084700 @default.
• W2956604098 hasAuthorship W2956604098A5090409167 @default.
• W2956604098 hasBestOaLocation W29566040981 @default.
• W2956604098 hasConcept C112705442 @default.
• W2956604098 hasConcept C119060515 @default.
• W2956604098 hasConcept C126322002 @default.
• W2956604098 hasConcept C142724271 @default.
• W2956604098 hasConcept C197934379 @default.
• W2956604098 hasConcept C204787440 @default.
• W2956604098 hasConcept C27081682 @default.
• W2956604098 hasConcept C2776432619 @default.
• W2956604098 hasConcept C2777288759 @default.
• W2956604098 hasConcept C2778375690 @default.
• W2956604098 hasConcept C2780930700 @default.
• W2956604098 hasConcept C42219234 @default.
• W2956604098 hasConcept C71924100 @default.
• W2956604098 hasConceptScore W2956604098C112705442 @default.
• W2956604098 hasConceptScore W2956604098C119060515 @default.
• W2956604098 hasConceptScore W2956604098C126322002 @default.
• W2956604098 hasConceptScore W2956604098C142724271 @default.
• W2956604098 hasConceptScore W2956604098C197934379 @default.
• W2956604098 hasConceptScore W2956604098C204787440 @default.
• W2956604098 hasConceptScore W2956604098C27081682 @default.
• W2956604098 hasConceptScore W2956604098C2776432619 @default.
• W2956604098 hasConceptScore W2956604098C2777288759 @default.
• W2956604098 hasConceptScore W2956604098C2778375690 @default.
• W2956604098 hasConceptScore W2956604098C2780930700 @default.
• W2956604098 hasConceptScore W2956604098C42219234 @default.
• W2956604098 hasConceptScore W2956604098C71924100 @default.
• W2956604098 hasFunder F4320309555 @default.
• W2956604098 hasIssue "4" @default.
• W2956604098 hasLocation W29566040981 @default.
• W2956604098 hasLocation W29566040982 @default.
• W2956604098 hasLocation W29566040983 @default.
• W2956604098 hasLocation W29566040984 @default.
• W2956604098 hasLocation W29566040985 @default.
• W2956604098 hasOpenAccess W2956604098 @default.
• W2956604098 hasPrimaryLocation W29566040981 @default.
• W2956604098 hasRelatedWork W1830687917 @default.
• W2956604098 hasRelatedWork W2003042623 @default.

• next